66
56
Growth Score 66 in past quarter
1 pts
Heat Score 56 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
102183
When ValueAct Capital Partners sees untapped value, it acts. The firm, known for its activist slant, buys large stakes in undervalued
Jeffrey Ubben: Co-Founder and ChairmanPast Role: ValueAct Capital, CEO- Jake Welch: Partner
About the Company
When ValueAct Capital Partners sees untapped value, it acts. The firm, known for its activist slant, buys large stakes in undervalued companies and works with their management to boost performance. Founded in 2000, ValueAct manages some $1.5 billion on behalf of institutional and wealthy individual investors. ValueAct's current portfolio
includes stakes in Advanced Medical Optics Inc. (contact lenses; nearly 15%). The company successfully thwarted Advanced Medical Optics' proposed acquisition of Bausch & Lomb in 2008, saying Advanced Medical could not successfully absorb its rival.
